Hoffmann-La Roche Limited (Roche), is one of the world’s leading health care companies with a global perspective on research, drug development and marketing. In Canada, Roche has always been guided by a commitment to research and development, pursuing innovative approaches in its search for superior healthcare products through the integration of its diagnostic and pharmaceutical divisions.

Roche provides financial support for highly qualified, promising, investigators-in-training to pursue further research in epidemiology, pharmacoeconomics, and/or any Roche-related therapeutic areas (oncology; viral & other infectious diseases; hematology & nephrology; inflammatory, autoimmune, and bone diseases; cardiovascular and metabolic diseases; genitourinary diseases; neurological and psychiatric diseases; and respiratory diseases).